Disease | pancreatic cancer |
Symptom | C0494165|liver metastases |
Sentences | 14 |
PubMedID- 25248901 | Two cases of pancreatic cancer with multiple liver metastases treated with radical treatment after successful treatment with gemcitabine plus s-1 therapy. |
PubMedID- 24130758 | Overall median survival time was 4.7 months and 1-year overall survival rate was 14% for pancreatic cancer with liver metastases . |
PubMedID- 24649263 | An alternative treatment option that may be beneficial in pancreatic cancer patients with liver metastases is the hepatic arterial infusion (hai) of chemotherapeutic agents. |
PubMedID- 25962312 | Auts2 is a potential therapeutic target for pancreatic cancer patients with liver metastases. |
PubMedID- 24959213 | A total of 164 pancreatic cancer patients with liver metastases that were treated with chemotherapy, radiation therapy and/or qyhj were analyzed. |
PubMedID- 22675973 | pancreatic cancer with liver metastases in a pregnant patient: case report and review of the literature. |
PubMedID- 25614082 | Our results support future investigations for pancreatic cancer patients with non-liver metastases and favorable immunological conditions. |
PubMedID- 23205084 | The increased levels of plasma mir-21, mir-25, mir-103 and mir-151, as well as the identification of cd133(+)ck18(+) cells in the pleural fluid of a pancreatic cancer patient with liver metastases, may regulate the molecular mechanisms involved in chemoresistance. |
PubMedID- 26462899 | Conclusions: our data suggest that patient's bmi, time between onset and diagnosis, histological grade, and venous tumor embolus are significantly correlated with postoperative liver metastases in patients with pancreatic cancer. |
PubMedID- 21276229 | So far, all animals have formed liver metastases of the injected pancreatic cancer cell lines. |
PubMedID- 23724404 | During the follow-up (1-6 years) of the remaining patients, two had further intervention for right subcostal incisional hernia and one presented non-resectable head pancreatic cancer with multiple liver metastases 1 year after cds. |
PubMedID- 24634093 | 15-lox-1 expression is absent in lymph node and liver metastases of pancreatic cancer 14. levels of 13-s-hode, the primary product of 15-lox-1, are inversely associated with cancer cells' ability to attach to endothelial cells and metastasize in mice 16–18. |
PubMedID- 20683216 | Multimodality treatment of pancreatic cancer with liver metastases using chemotherapy, radiation therapy, and/or chinese herbal medicine. |
PubMedID- 25318603 | Portal vein-circulating tumor cells predict liver metastases in patients with resectable pancreatic cancer. |
Page: 1